Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Thyroid Diseases × Iodine-131 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 3 Thyroid Cancer, Papillary 2 Adenocarcinoma, Follicular 2 Thyroid Diseases 1 Prostatic Neoplasms 1 Lymphoma, T-Cell 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00673010 2025-10-09

Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed

Thyroid Diseases, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡